Anzeige
Mehr »
Samstag, 14.02.2026 - Börsentäglich über 12.000 News
20 Mio. € Bewertung. Zwei zugelassene Psychedelika-Produkte. NASDAQ-Uplist in Arbeit.
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2PDWM | ISIN: CA12532H1047 | Ticker-Symbol: CJ5A
Tradegate
13.02.26 | 18:00
62,98 Euro
+0,32 % +0,20
1-Jahres-Chart
CGI INC Chart 1 Jahr
5-Tage-Chart
CGI INC 5-Tage-Chart
RealtimeGeldBriefZeit
62,6862,9213.02.
62,6262,9413.02.
ACCESS Newswire
636 Leser
Artikel bewerten:
(2)

CGI and Tribun Health Expand Digital Pathology Leadership in Denmark with New Regional Win

PARIS, FR / ACCESS Newswire / March 20, 2025 / CGI and Tribun Health have won their second multi-site regional project in Denmark, expanding their successful partnership in digital pathology. Following their initial victory in Region Sjælland, the duo has now secured a major contract in Region Nordjylland, further strengthening their position in Denmark's healthcare digitalization efforts.

Pathologist Using CaloPix

Pathologist Using CaloPix
Pathologist Utilizing CaloPix for Advanced Digital Pathology Workflow

As the prime integrator, CGI is leading the project while Tribun Health provides its CaloPix® solution - a fully DICOM-compliant image management system designed to enhance pathology workflows, interoperability, and multi-site collaboration.

"Winning a second regional project in Denmark reaffirms the strength of our partnership with CGI and the trust placed in our solutions," said Jean-François Pomerol, CEO of Tribun Health. "With CaloPix, we are enabling seamless integration within hospital ecosystems, boosting efficiency, and enhancing diagnostic precision across multiple sites."

CGI and Tribun Health Strengthen Their Presence in Danish Healthcare

The new deployment in Region Nordjylland underscores the growing demand for scalable, interoperable digital pathology solutions. By implementing CaloPix® IMS, healthcare pathologists across the region will benefit from standardized imaging, enhanced remote collaboration, and optimized workflows.

Henrik Mejlgaard, Vice President of CGI's Health Solutions in Denmark, emphasized the importance of this collaboration. "Our continued success in Denmark with Tribun Health highlights the critical role of digital transformation in pathology. Region Nordjylland's investment in advanced imaging and interoperability through CaloPix IMS will enable more efficient diagnostics and better patient outcomes. We look forward to supporting the region in its transition to a fully digital pathology workflow."

Driving Innovation in Scandinavian Healthcare

With two major regional wins in Denmark, CGI and Tribun Health are well-positioned to drive further innovation and efficiency in pathology across Denmark and beyond. This expansion reinforces their commitment to providing state-of-the-art digital pathology solutions that empower pathologists and healthcare institutions with precision, scalability, and AI-driven insights.

About Tribun Health

Tribun Health is a global leader in digital pathology, delivering award-winning solutions that enhance workflow efficiency, and diagnostic precision. We empower hospitals and laboratories transitioning from glass slide pathology to fully digital solutions, leveraging AI and data-driven technology to improve accuracy and reduce turnaround times. Our mission is simple: to ensure every cancer patient receives a timely, informed diagnosis - because every moment matters. By advancing pathology with cutting-edge innovation, we are shaping the future of cancer care. Follow us on LinkedIn and X.

About CGI

Founded in 1976, CGI is among the largest independent IT and business consulting services firms in the world. With 91,500 consultants and professionals across the globe, CGI delivers an end-to-end portfolio of capabilities, from strategic IT and business consulting to systems integration, managed IT and business process services and intellectual property solutions. CGI works with clients through a local relationship model complemented by a global delivery network that helps clients digitally transform their organizations and accelerate results. CGI Fiscal 2023 reported revenue is $14.30 billion and CGI shares are listed on the TSX (GIB.A) and the NYSE (GIB). Learn more at cgi.com.

Contact Information

Andreia Beyer
VP, Global Marketing & Managing Director, North America
abeyer@tribun.health
+1 (416) 565-0474

Peter Sand
Marketing & Communications Business Partner, CGI Denmark
peter.sand@cgi.com
+45 29 48 11 12

.

SOURCE: Tribun Health



© 2025 ACCESS Newswire
Favoritenwechsel - diese 5 Werte sollten Anleger im Depot haben!
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.